IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF

Anne-Marie Baird1, Steven G Gray, Kenneth J O'Byrne

  • 1Thoracic Oncology Research Group, Institute of Molecular Medicine, Trinity College Dublin, Ireland.

European Journal of Cancer (Oxford, England : 1990)
|May 14, 2011
PubMed
Abstract

Insights

Interleukin-20 (IL-20) and its receptors are dysregulated in non-small cell lung cancer (NSCLC) and are epigenetically regulated. Targeting this pathway may offer a new therapeutic strategy for lung cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Interleukin-20 (IL-20) is a cytokine involved in skin and hematopoietic cell development.
  • IL-20 exhibits potential anti-angiogenic effects in non-small cell lung cancer (NSCLC) by downregulating COX-2.
  • The role of IL-20 in NSCLC pathogenesis warrants further investigation.

Purpose of the Study:

  • To investigate the expression and epigenetic regulation of the IL-20 family in NSCLC.
  • To determine the effect of IL-20 on angiogenesis-related factors in NSCLC.

Main Methods:

  • Examined IL-20 and its receptor expression (IL-20RA/B, IL-22R1) in NSCLC tumors and cell lines.
  • Assessed epigenetic regulation via histone modifications and DNA methylation.
  • Investigated the impact of IL-20 on VEGF family members.

Main Results:

  • IL-20 and its receptors are frequently dysregulated in NSCLC, with elevated IL-20RB mRNA and protein levels.
  • Epigenetic mechanisms, including histone modifications and DNA methylation, regulate IL-20 family expression.
  • Recombinant IL-20 treatment reduced VEGF family member expression at the mRNA level.

Conclusions:

  • The IL-20 gene family is epigenetically dysregulated in NSCLC.
  • Epigenetic targeting of the IL-20 family presents a potential therapeutic strategy for lung cancer.
  • Further research is needed to clarify the anti-angiogenic properties of IL-20 in NSCLC.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...